Could artificial intelligence be the solution for detecting and managing a complex condition like Alzheimer's disease? A team of researchers thinks so. They employed a novel application of supervised machine learning and predictive modeling to demonstrate and validate the cross-sectional utility of MemTrax as a clinical decision support screening tool for assessing cognitive impairment. They introduce supervised machine learning as a new approach and value-added complementary tool in cognitive brain health assessment and related patient care and management.